GoodRx, a prescription savings platform, partnered with ARS Pharmaceuticals to provide the lowest discounted cash price for neffy, a needle-free epinephrine nasal spray for type I allergic reactions.
Through this partnership, neffy will be available for USD 199 for a pack of two single-use devices at over 70,000 pharmacies nationwide, exclusively through GoodRx. This collaboration aims to enhance the accessibility and affordability of anaphylaxis treatment, offering a needle-free alternative to traditional auto-injectors for millions of Americans, especially children and adults who need to carry epinephrine.
neffy, recently approved by the FDA in August, is the first needle-free treatment for type I allergic reactions, including anaphylaxis, for adults and children weighing 30 kg (66 lbs) or more. This partnership aligns with GoodRx's mission to make essential medications more accessible and affordable while promoting healthcare innovation.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.